Science

ProQR soon to announce proof-of-concept results for novel cystic fibrosis treatment
The company continues to make good progress, a little less than a month after having received Fast Track designation from the Food and Drug Administration (FDA) for its QR-010 molecule. Co-funded under H2020, QR-010 is expected to treat cystic fibrosis (CF) patients who carry the common ∆F508 mutation — that is, 70 % of CF patients.
Trending Science: Unlocking the mysteries of the full moon
Did you sleep badly on the night between Thursday 18 August and Friday 19 August? Perhaps you had a particularly vivid nightmare or inexplicably woke up much earlier than usual. On that night there was a particularly large full moon, known in August as a Full Sturgeon Moon. Traditionally, a full moon is not only said to be able to turn humans into werewolves, but less excitedly, is a harbinger of a restless night’s sleep.
EU research finds existing navigational data can help pilots avoid turbulence and improve air travel safety
Research aided by the DELICAT project has highlighted how turbulence can be detected in a much faster and more efficient way, using data already routinely broadcast by commercial airlines.
EU research finds existing navigational data can help pilots avoid turbulence and improve air travel safety
Research aided by the DELICAT project has highlighted how turbulence can be detected in a much faster and more efficient way, using data already routinely broadcast by commercial airlines.
Scientists uncover clues to prevent disease pandemics
EU-funded researchers have examined new ways of rapidly detecting infectious pathogens - such as rabies and influenza - in order to prevent pandemics.
ProQR soon to announce proof-of-concept results for novel cystic fibrosis treatment
The company continues to make good progress, a little less than a month after having received Fast Track designation from the Food and Drug Administration (FDA) for its QR-010 molecule. Co-funded under H2020, QR-010 is expected to treat cystic fibrosis (CF) patients who carry the common ∆F508 mutation — that is, 70 % of CF patients.
Major cinema breakthrough could allow for glasses-free 3D
A team of US and Israeli researchers, partly funded by the EU, have developed a truly pioneering cinema screen that can show 3D films without the need for glasses.
Holonomy and singular foliations
Holonomy has proven to be a valuable tool for understanding constrained motion, where an object is desired to move in more dimensions than it is allowed to. EU-funded mathematicians recently extended the use of holonomy from regular foliations to singular foliations.
EU researchers discover that magna build-up may put Salvadoran capital at risk
Researchers from the EU-funded VUELCO project have found that the build-up of magma 6 kilometres below El Salvador’s Ilopango caldera means that the country’s capital, San Salvador, may be at risk from future volcanic eruptions.
ProQR soon to announce proof-of-concept results for novel cystic fibrosis treatment
The company continues to make good progress, a little less than a month after having received Fast Track designation from the Food and Drug Administration (FDA) for its QR-010 molecule. Co-funded under H2020, QR-010 is expected to treat cystic fibrosis (CF) patients who carry the common ∆F508 mutation — that is, 70 % of CF patients.

Study in Poland